-
Document de presse | 2018.06.14
HIV: “controller” patient research holds promise for cell therapy
Rare patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not go on to develop AIDS. The ability of these patients, known as "HIV controllers", to limit HIV replication appears to result from a highly effective immune response. Scientists from the Pasteur Institute and Inserm, together with colleagues from Monash University, Melbourne, found that...
-
News | 2018.06.15
In remembrance of Dr François Rouet
Our colleague and friend François Rouet passed away on June 13, 2018 at the age of 53 following a long illness. The Institut Pasteur International Network wishes to pay tribute to this passionate scientist and public health man who has dedicated his career to improving the care of patients in the most disadvantaged countries.Trained pharmacist, François performs his national service in Cameroon...
-
News | 2018.06.18
Pasteur International Network Association supported 3 statements at World Health Assembly 2018
In official relation with WHO since 2016, the Pasteur International Network Association, represented by Nadia Khelef, presented 3 statements during the 71st World Health Assembly held in Geneva from 21 to 26 May 2018.The first statement supported the program to combat the global shortage of effective and affordable quality medicines and vaccines and to promote access to them. In particular, the...
-
Document de presse | 2018.06.19
In-Cell-Art, the Institut Pasteur and BioNet-Asia announce the collaborative development of a dengue vaccine candidate
In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia (BNA), an innovative vaccine developer, and the research team led by Dr. Anavaj Sakuntabhai at the Functional Genetics of Infectious Diseases Unit, Institut Pasteur Paris France, (GFMI-IP), announce today the development of Nanotaxi® formulated DNA vaccine to induce strong immune response against...
-
News | 2018.06.20
An international conference on Emerging Infections & Pandemic Risk
On June 21 and 22, 2018, an international conference on Emerging Infections and Pandemic Risk, co-organized by the Institut Pasteur and the SCOR Foundation for Science, brings some of the world’s leading scientists and public health professionals together at the Institut Pasteur (Paris). Their target: to examine the emergence and spread of epidemics, and to look at new tools and technologies that...
-
News | 2018.06.20
MediLabSecure: 4 years of health security improvement against vector-borne diseases in the Mediterranenan and Black Sea Regions
Launched in 2014, the MediLabSecure project is about to be completed. A global conference organized at the Institut Pasteur in Paris on 25-27th June 2018, will gather more than 100 delegates from the 19 participant countries. An occasion to take stock of the project achievements and engage a global reflexion on the possible next step.“On a regional level, the MediLabSecure network has...
-
Document de presse | 2018.05.31
Professor Christine Petit receives the 2018 Kavli Prize
The Institut Pasteur, the Collège de France, the French Academy of Sciences and Inserm are honored to announce that the Norwegian Academy of Science and Letters has decided to award the 2018 Kavli Prize in Neuroscience to Christine Petit for her pioneering work on the molecular and neural mechanisms of hearing. This prize, which is awarded every two years, consists of a $1 million (U.S.) fund...
-
Report | 2018.06.22
Microscopes – observing living organisms in order to fight disease
With the naked eye, humans can make out a detail measuring roughly 1 mm from a distance of 3 meters. Titan Krios™, the world's most powerful microscope, which will be officially inaugurated in July 2018 at the Institut Pasteur, magnifies objects millions of times (compared with just 10x for the earliest microscopes) and reveals what is happening at the atomic level. Scientists investigating...
-
Document de presse | 2018.06.21
HKU to Collaborate on Biomedical Innovation with the Institut Pasteur and Hong Kong Science and Technology Parks Corporation
The University of Hong Kong (“HKU”), the Institut Pasteur and Hong Kong Science and Technology Parks Corporation (“HKSTP”) signed a Memorandum of Understanding (“MoU”) in Paris today (June 21, 2018) to set up a joint biomedical research centre, witnessed by a high-level delegation led by The Hon Mrs Carrie Lam, the Chief Executive of the Hong Kong Special Administrative Region; and Mr Nicholas W...
-
News | 2018.07.02
Roman Thibeaux’s joust with bacterial armor
Countering the bacteria responsible for leptospirosis by attacking the "shield" they make to protect themselves: this is the strategy that Roman Thibeaux, a young researcher at the Institut Pasteur de Nouvelle-Calédonie is trying to develop. Born on the island, he left the South Pacific region for a decade before coming back better armed.Roman Thibeaux has been immersed in a medical environment...
